Our Insurance page explains how coverage works for different therapies
Novo Nordisk's Ozempic pill, the only FDA-approved oral peptide GLP-1 medication for adults with type 2 diabetes, soon to be available in the US With an updated formulation of semaglutide tablets and new branding, Ozempic will be available in a pill Ozempic (semaglutide) pill is the only oral GLP-1 medicine approved for both primary and secondary cardiovascular risk reduction of heart attack, stroke, and death in adults with type 2 diabetes at high risk for these events, including those with known heart disease1 Ozempic pill will be covered by insurance for most patients with type 2 diabetes for as little as $25 and available via self-pay through NovoCare Pharmacy and major telehealth providers PLAINSBORO, N.J., May 1, 2026 /PRNewswire/ -- Novo Nordisk announced that starting Monday, May 4, Ozempic (semaglutide) tablets 1.5 mg, 4 mg, and 9 mg will be available for adults with type 2 diabetes in the US
The risk of hypoglycaemia (low blood sugar) is generally low with GLP-1 medications when used alone
Fast facts About Laser liposuction is a minimally invasive cosmetic procedure that uses a laser to melt away fat under the skin
While Novo Nordisk and Structure Therapeutics differ significantly in scale and commercial maturity, the comparison is becoming increasingly relevant amid intensifying market competition
